SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPoolbeg Pharma Share News (POLB)

Share Price Information for Poolbeg Pharma (POLB)

Share Price is delayed by 15 minutes
Get Live Data
7.60    -0.10 (-1.30%)
Bid:
7.50
Ask:
7.70
Spread: 0.20 (2.667%)
Market Cap: £53.59m
POLB Live PriceLast checked at - London Stock Exchange

Intraday Poolbeg Pharma Share Chart

Poolbeg Pharma News

TRADING UPDATES: Poolbeg patent boost; Resolute Mining resource up
8 Mar 2023

TRADING UPDATES: Poolbeg patent boost; Resolute Mining resource up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and Tuesday not separately reported by Allian...

TRADING UPDATES: Cordiant Digital hails portfolio firm's deal with AMC
2 Mar 2023

TRADING UPDATES: Cordiant Digital hails portfolio firm's deal with AMC

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

AIM WINNERS & LOSERS: Metal Tiger goes into the Strata but out of AIM
2 Mar 2023

AIM WINNERS & LOSERS: Metal Tiger goes into the Strata but out of AIM

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

TRADING UPDATES: Tungsten West 'largest Western tungsten producer'
16 Jan 2023

TRADING UPDATES: Tungsten West 'largest Western tungsten producer'

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Poolbeg expands its focus molecule into oncology
16 Jan 2023

Poolbeg expands its focus molecule into oncology

(Sharecast News) - Poolbeg Pharma announced the strategic expansion of 'POLB 001' into oncology on Monday.

Poolbeg Pharma says initial POLB 001 data shows positive response
9 Jan 2023

Poolbeg Pharma says initial POLB 001 data shows positive response

(Alliance News) - Poolbeg Pharma PLC on Monday said initial data analysis in its POLB 001 LPS challenge trial indicated a clear anti-inflammatory resp...

TRADING UPDATES: Atlantis Japan underperforms; Bellevue lowers payout
21 Dec 2022

TRADING UPDATES: Atlantis Japan underperforms; Bellevue lowers payout

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Poolbeg identifies new drug candidates with OneThree
21 Dec 2022

Poolbeg identifies new drug candidates with OneThree

(Sharecast News) - Biopharmaceutical company Poolbeg Pharma has successfully identified potential new drug candidates from its respiratory syncytial v...